{
    "id": 14083,
    "fullName": "PDGFRB N666K",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "PDGFRB N666K lies within the protein kinase domain of the Pdgfrb protein (PMID: 26455322). N666K results in constitutive activation of Pdgfrb and is transforming in cell culture (PMID: 26455322).",
            "references": [
                {
                    "id": 3957,
                    "pubMedId": 26455322,
                    "title": "PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26455322"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5159,
        "geneSymbol": "PDGFRB",
        "terms": [
            "PDGFRB",
            "CD140B",
            "IBGC4",
            "IMF1",
            "JTK12",
            "KOGS",
            "PDGFR",
            "PDGFR-1",
            "PDGFR1",
            "PENTT"
        ]
    },
    "variant": "N666K",
    "createDate": "11/19/2015",
    "updateDate": "11/19/2015",
    "referenceTranscriptCoordinates": {
        "id": 175041,
        "transcript": "NM_002609",
        "gDna": "chr5:g.150124275G>C",
        "cDna": "c.1998C>G",
        "protein": "p.N666K",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8954,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Gleevec (imatinib) inhibited PDGFRB downstream signaling and proliferation of transformed cells expressing PDGFRB N666K in culture (PMID: 26455322).",
            "molecularProfile": {
                "id": 14340,
                "profileName": "PDGFRB N666K"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3957,
                    "pubMedId": 26455322,
                    "title": "PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26455322"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8956,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study,Tasigna (nilotinib) inhibited PDGFRB downstream signaling and proliferation of transformed cells expressing PDGFRB N666K in culture (PMID: 26455322).",
            "molecularProfile": {
                "id": 14340,
                "profileName": "PDGFRB N666K"
            },
            "therapy": {
                "id": 829,
                "therapyName": "Nilotinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3957,
                    "pubMedId": 26455322,
                    "title": "PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26455322"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8955,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Iclusig (ponatinib) inhibited PDGFRB downstream signaling and proliferation of transformed cells expressing PDGFRB N666K in culture (PMID: 26455322).",
            "molecularProfile": {
                "id": 14340,
                "profileName": "PDGFRB N666K"
            },
            "therapy": {
                "id": 877,
                "therapyName": "Ponatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3957,
                    "pubMedId": 26455322,
                    "title": "PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26455322"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 14340,
            "profileName": "PDGFRB N666K",
            "profileTreatmentApproaches": [
                {
                    "id": 7088,
                    "name": "PDGFR-beta Inhibitor",
                    "profileName": "PDGFRB N666K"
                },
                {
                    "id": 7087,
                    "name": "PDGFR Inhibitor (Pan)",
                    "profileName": "PDGFRB N666K"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 175041,
            "transcript": "NM_002609",
            "gDna": "chr5:g.150124275G>C",
            "cDna": "c.1998C>G",
            "protein": "p.N666K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 175042,
            "transcript": "XM_011537658",
            "gDna": "chr5:g.150124275G>C",
            "cDna": "c.1998C>G",
            "protein": "p.N666K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 175040,
            "transcript": "XM_011537659",
            "gDna": "chr5:g.150124275G>C",
            "cDna": "c.1998C>G",
            "protein": "p.N666K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}